Patients with malignant and nonmalignant respiratory diseases often suffer from dyspnea during end-of-life care. Terminal suffering of patients with nonmalignant diseases, such as chronic obstructive pulmonary disease, is comparable with or sometimes surpasses the patients with lung cancer.. There are several studies on palliative care for malignant diseases, but very few studies have investigated palliative care for nonmalignant diseases. We focused on the last stage of terminal care and evaluated the status and challenges of palliative care for patients with respiratory diseases at our hospital. We aimed to identify the areas that are lacking in the treatment and palliative care and understand the problems encountered in the patients with malignant and nonmalignant respiratory diseases. We included 90 patients who had died of malignant or nonmalignant respiratory diseases from January 1, 2018, to January 31, 2019 at the Department of Respiratory and Allergy Medicine, Showa University Hospital and compared the actual conditions between the two groups. The number of patients with malignant and nonmalignant diseases was 31 and 59, respectively. We observed that opioids were used significantly less frequently for nonmalignant diseases than for malignant diseases. Furthermore, rehabilitation was performed significantly less frequently in patients with malignant diseases. Although end-of-life care for malignant and nonmalignant diseases differs in many aspects, the results suggest an overlap in terms of opioid administration and rehabilitation. Thus, additional interventions should be considered. During end-of-life care, irrespective of whether the disease is malignant or nonmalignant, it is necessary to determine whether adequate palliative care interventions are provided.
View full abstract